BET protein inhibition rewires the vascular-fat interface in cardiometabolic disease

29 August 2025 (09:30 - 09:40)

Organised by:

Video

Abstract

Slides

Sign in for access options

About the speaker

Assistant Professor Alessandro Mengozzi

University of Pisa, Pisa (Italy)

4 More presentations in this session

Presentation thumbnail

Liraglutide attenuates high glucose-induced 'trained immunity' in cd34+ hematopoietic stem cells

Doctor G. Damiano (Milan, IT)

Abstract Slides Video

Presentation thumbnail

Targeting Perilipin 2 alleviates vascular aging through regulation of lipid droplet-mitochondria tethering and fatty acid oxidation

Doctor T. Lu (Tianjin, CN)

Abstract Slides Video

Presentation thumbnail

Heterozygous loss-of-function mutation in TBX5 causes dysregulation of energy metabolism, mitochondrial metabolic pathways and cholesterol metabolism disturbing cardiomyocyte cell physiology

Doctor M. Dressen (Munich, DE)

Abstract Slides Video

Presentation thumbnail

Epicardial adipose tissue-derived kynurenic acid induces atrial lymphatic dysfunction in atrial fibrillation.

Doctor M. Takahashi (Oita, JP)

Abstract Slides Video

Access the full session

Session thumbnail

Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease

The Event

Event poster

ESC Congress 2025

29 August 2025 09:30 CET

You may be interested in

Congress Presentation

Targeting BRD4-HK2 reverses the meta-inflammatory shift in perivascular adipose tissue and rescues cardiometabolic vascular dysfunction.

Congress Session

Epigenetic targets in cardiovascular disease

Congress Presentation

Emerging therapies to prevent perivascular fat dysfunction in cardiometabolic heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources